Synektik (FRA:A2P) Other Current Receivables: €0.5 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:A2P Synektik SA FRA:A2P
67 GF Score
Price €87.05
GF Value €53.38
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Synektik Other Current Receivables?

Synektik FRA:A2P -3.01% 67 Other Current Receivables is €0.5 Mil as of Mar. 2026. GuruFocus rates FRA:A2P with a GF Score™ of 67/100 and a GF Value™ of €53.38 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Synektik's Other Current Receivables for the quarter that ended in Mar. 2026 was €0.5 Mil.

Synektik's quarterly Other Current Receivables increased from Sep. 2025 (€0.48 Mil) to Dec. 2025 (€0.50 Mil) and increased from Dec. 2025 (€0.50 Mil) to Mar. 2026 (€0.51 Mil).

Synektik's annual Other Current Receivables increased from Sep. 2023 (€0.43 Mil) to Sep. 2024 (€0.46 Mil) and increased from Sep. 2024 (€0.46 Mil) to Sep. 2025 (€0.48 Mil).

Synektik Other Current Receivables Related Terms

Synektik Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Synektik's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synektik Other Current Receivables Chart

Synektik Annual Data
Trend Dec15 Dec16 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.39 0.43 0.46 0.48

Synektik Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.53 0.48 0.48 0.50 0.51
FRA:A2P
67GF Score
Synektik SA FRA:A2P
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synektik Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.5 Mil mean?
Synektik (FRA:A2P) has a Other Current Receivables of €0.5 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Synektik and its competitors.
Is Synektik's Other Current Receivables too high?
Synektik's current Other Current Receivables is €0.5 Mil. Overall, Synektik has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Synektik's Other Current Receivables compare to ABT and SYK?
Synektik's Other Current Receivables of €0.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Synektik and its competitors. Synektik's current Other Current Receivables is €0.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synektik stock overvalued right now?
Based on GuruFocus' analysis, Synektik (FRA:A2P) is currently considered Significantly Overvalued. The stock's GF Value™ is €53.38, compared to a current price of €87.05 — trading 63.1% above its estimated fair value. The current Other Current Receivables is €0.5 Mil. Synektik's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Synektik (FRA:A2P), the current Other Current Receivables is €0.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synektik (FRA:A2P) Overvalued in 2026?

Based on GuruFocus' analysis, Synektik stock appears to be overvalued. The current stock price of €87.05 is trading 63.1% above its estimated GF Value™ of €53.38. GuruFocus considers Synektik to be Significantly Overvalued.

Key valuation signals for FRA:A2P:

  • Other Current Receivables: €0.5 Mil
  • GF Value™: €53.38 vs. price of €87.05 (63.1% above fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the FRA:A2P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synektik Business Description

Other Exchanges SNT:Poland
Address Aleja Wincentego Witosa 31, Warsaw, POL, 00-710
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
67GF Score

Get the complete analysis for FRA:A2P

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€87.05
Price
€53.38
GF Value